Transient Acute Kidney Injury in the Postoperative Period: It Is Time to Pay Closer Attention.
C. D. de Virgilio,Dennis Y Kim
DOI: https://doi.org/10.1001/jamasurg.2015.4660
2016-05-01
JAMA Surgery
Abstract:Manyofushavehad theunsettlingexperienceofwatching the serum creatinine level rise or the urine output dwindle following a complex vascular operation. As kidney function deteriorates,we steel ourselves for the inevitable need for dialysis. The second guessing begins. Was it the contrast? The brief intraoperative hypotension? Or, perhaps a nephrotoxic drug? As the creatinine level ebbs, we breathe a sigh of relief. However, a growing body of literature indicates that we are lulled by a false sense of security. As highlighted in thearticlebyHuberet al,1 transientacutekidney injury (AKI) in thepostoperativeperiodhas lasting, long-term,mortal consequences on the heart. On first pass, it seems counterintuitive that a brief period ofAKIwouldhave lasting effects, particularly in apatientwith normal kidney functionatbaseline.Onemustnot forget, however, that an extreme loss of renal function is required to develop AKI in such patients. Alarmingly, nearly half of the patients in thestudybyHuberandcolleaguesdevelopedAKI, and even transient AKI was associated with a 31% increase in 10year adjusted cardiovascular mortality. This begs the question: what are the potential links between transient postoperative AKI and long-term cardiovascular death? The answer may lie in the concept of organ cross talk, which refers to the mechanismwhereby injury of one organ affects the function of distant organs. The ischemia-reperfusion associated with AKI leads to an initial insult of the renal tubule and renal vascular endothelium.2 This appears to trigger a proinflammatory cascade, with the release of cellular and soluble mediators that lead to remote cardiac injury byvariousmechanisms including neutrophil infiltration,maladaptive neurohumoral responses, and cardiac myocyte apoptosis.3 An imbalance in cardiac homeostasis ensues, with the potential for long-term myocardial dysfunction. The results of the study by Huber and colleagues should prompt a call to action in terms of earlier diagnosis, treatment, andprevention of postoperativeAKI. Recently, urinary markers of cell cycle arrest have been validated for the early identification of AKI far in advance of clinical manifestations suchasoliguriaor azotemia.4Thesenovelbiomarkersmay furnish physicians with a narrow window to reverse or altogether avoid the development of AKI. Goal-directed intraoperativemeasures tomaximize renalperfusionandtheearlyuse of renal replacement therapy may also have a role in prevention and treatment, respectively. Perhaps evenmore exciting is the application of preoperative therapeutic interventions suchas remote ischemicpreconditioning,which inarecent trial was associatedwith a significantly reduced rate ofAKI followingcardiac surgery.5Regardlessof thestrategiesused, it is readily apparent that it is time to start paying closer attention to postoperative AKI.